Company: FVN
Filing Date: 2025-05-02
Form Type: S-4
Source: 0001829126-25-003304
Chunk: 232

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-02
Form: S-4
Chunk 232
---
 adjustments were required to eliminate activities between the companies.

There is no historical activity with respect to Merger Sub. Accordingly, no adjustments were required with respect to these entities in the pro forma combined financial statements.

The unaudited pro forma combined financial information has been prepared assuming two alternative levels of redemption into cash of Future Vision’s ordinary shares:

| ● | Scenario 1 — Assuming no other Future Vision’s shareholders exercise their redemption rights, all Future Vision’s shares previously subject to redemption for cash amounting to approximately $53 million would be transferred to shareholders’ equity; and |

| ● | Scenario 2 — Assuming the maximum number of Future Vision’s public shares of 5,750,000 shares subject to redemption are redeemed for cash by Future Vision’s shareholders, cash required at approximately $58 million would be paid out in cash at the closing of the Business Combination. |

Included in the shares outstanding and weighted average shares outstanding as presented in the pro forma combined financial statements are approximately 9,950,250 ordinary shares to be issued to the VIWO’s shareholders, such amount calculated using estimated consideration of $100 million paid to the VIWO’s shareholders.

Upon the completion of the Business Combination, assuming, among other things, that no Future Vision’s public shareholder exercises redemption rights (assuming automatic conversion of rights into ordinary shares), Future Vision’s public shareholders, the Sponsor, and VIWO’s shareholders will own approximately 34.89%, 9.74% and 54.89% of the outstanding shares of New VIWO, respectively.

If 5,750,000 ordinary shares of Future Vision subject to redemption are ultimately fully redeemed, Future Vision’s public shareholders, the Sponsor and VIWO’s shareholders are expected to own approximately 4.65%, 14.27%, and 80.39% of New VIWO, respectively, of the ordinary shares following the consummation of the Business Combination assuming that the closing will take place no later than March 13, 2026. As such, Future Vision’s shareholders who do not redeem their ordinary shares of Future Vision will experience immediate and material dilution following the consummation of the Business Combination.

<div align='center'>137</div>

<div align='center'>UNAUDITED PRO FORMA COMBINED BALANCE SHEET

AS OF DECEMBER 31, 2024

(In US$, except for share, or otherwise noted)</div>

|                                                                                                                                                        |     |      |             |     |               |            |     | Scenario 1            |